Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
Clinical trial NCT00904098 · COMPLETED
Trial details
- NCT number
- NCT00904098
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2006-02-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.